Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acne Infection01:27

Acne Infection

98
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
98
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Cancer Therapies02:49

Cancer Therapies

8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

619
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
619
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Confocal Fluorescence Microscopy01:16

Confocal Fluorescence Microscopy

16.0K
Confocal microscopy is an advanced microscopic technique. The prime advantage of the confocal microscope over other microscopy techniques is its ability to block the out-of-focus light from the illuminated samples using pinholes. It is widely used with fluorescence optics to obtain high-resolution, sharp contrast images. Unlike optical microscopes, confocal microscopes use a focused beam of light laser to scan the entire sample surface at different z-planes. These microscopes are, therefore,...
16.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Global Delphi Consensus on Acne and the Microbiome: Integrating International Expertise for Innovative Prevention and Therapeutic Strategies.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

NECASA II: A Practical Algorithm Integrating Skincare in the Management of Adult Female Acne in the Nordic European Countries.

Journal of drugs in dermatology : JDD·2025
Same author

Validation of the Acne Core Outcomes Research Network Patient Global Assessment for Acne.

JAMA dermatology·2025
Same author

International expert consensus recommendations for the use of dermocosmetics in acne.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Evaluation of the measurement properties and validation of the Skindex-16 among patients with acne.

Journal of the American Academy of Dermatology·2024
Same author

Methodological innovations and stakeholder involvement in core outcome sets for skin diseases: a survey of the C3 working groups.

Archives of dermatological research·2024

Related Experiment Video

Updated: May 6, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

1.0K

Emerging therapies in rosacea.

Alison Layton1, Diane Thiboutot

  • 1Department of Dermatology, Harrogate District Hospital, United Kingdom.

Journal of the American Academy of Dermatology
|November 16, 2013
PubMed
Summary
This summary is machine-generated.

New research offers promising treatments for rosacea, a common skin condition. Subantimicrobial-dose doxycycline shows potential for managing erythematic symptoms, improving patient outcomes.

Keywords:
SDDcarvedilolivermectinmedical therapypermethrinrosaceasubantimicrobial dose doxycyclinesubantimicrobial-dose doxycycline

More Related Videos

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

2.1K

Related Experiment Videos

Last Updated: May 6, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

1.0K
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

2.1K

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Rosacea is a prevalent skin condition with diverse clinical manifestations.
  • Understanding rosacea's pathophysiology reveals new therapeutic targets.
  • There is a clinical need for effective treatments addressing rosacea-related erythema.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for rosacea.
  • To highlight the potential of subantimicrobial-dose doxycycline in managing rosacea symptoms.

Main Methods:

  • Review of existing literature on rosacea pathophysiology and treatment.
  • Analysis of systemic and topical therapeutic options.
  • Evaluation of subantimicrobial-dose doxycycline's efficacy.

Main Results:

  • Both systemic and topical therapies have demonstrated efficacy in rosacea management.
  • Subantimicrobial-dose doxycycline presents a promising option for treating erythematic symptoms.
  • Ongoing research is expected to yield novel treatments.

Conclusions:

  • Advances in understanding rosacea pathophysiology are driving the development of new treatments.
  • Subantimicrobial-dose doxycycline is a notable therapeutic advancement for rosacea.
  • Future innovations aim to enhance patient outcomes for this common skin disorder.